Published in:BIO International Convention, San Diego CA
Dr. Willyanne DeCormier Plosky, Program Manager at the MRCT Center, presented on this panel, which explored emerging principles and concrete strategies for addressing demographic disparities and achieving representativeness in clinical trials. The panel was organized and moderated by Lindsay Cobbs (BeiGene USA Inc.), and also included Melika Davis (BeiGene USA Inc.), Jacqueline Corrigan-Curay (FDA); Meg Alexander (Ovid Therapeutics Inc.), and Tesheia Johnson (Yale University) as speakers. See the recording here.
Published in:BIO International Convention, San Diego CA
Dr. Willyanne DeCormier Plosky, Program Manager at the MRCT Center, presented on this panel, which was organized by the MRCT Center to discuss the origins, development, structure, and lessons learned from pilot testing of the Equity by Design (EbD) in Clinical Research Metrics Framework. The panel was moderated by Camelia Thompson (BIO), and also included Neha Londono (Seagen Inc.); and Inez Ruiz-White (Otsuka Pharmaceuticals) as speakers. See the recording here.
Countway Library at Harvard Medical School, Boston, MA
Topic: Ethical Challenges of Phase 1 Clinical Trials.
Dr. Barbara E. Bierer, MRCT Center Faculty Director, will be a commentator at the Harvard Medical School Center for Bioethics’ September Research Ethics Consortium.
Click here to view the Annual Meeting Slides (for sponsors only).
The principal topics discussed at the MRCT Center 2018 Annual Meeting were:
European Union General Data Protection Regulation (GDPR)
Representation of Diverse Populations
Advancing the Study of Clinical Trials
Capacity Building
Health Literacy in Clinical Research.
The meeting was followed by the Executive and Steering Committee meeting in the afternoon (1:00 PM -5:00 PM), which was open to MRCT Center sponsors only.
